Skip Navigation

European Heart Journal 1999 20(4):256-262; doi:10.1053/euhj.1998.1221
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fox, K.F.
Right arrow Articles by Sutton, G.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fox, K.F.
Right arrow Articles by Sutton, G.C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Review Article

New perspectives on heart failure due to myocardial ischaemia

K.F. Foxa,f1, M.R. Cowiea, D.A. Wooda, A.J.S. Coatsa, P.A. Poole-Wilsona and G.C. Suttonb

a Cardiac Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, London
b Hillingdon Hospital, Uxbridge, Middlesex, U.K.

Received June 2, 1998; accepted July 12, 1998

f1 Correspondence: Dr Kevin F. Fox, Cardiac Medicine (Clinical Epidemiology Group), Imperial College School of Medicine at the National Heart and Lung Institute, Dovehouse Street, London SW3 6LY, U.K.

E, Braunwald

References

  1. Parameshwar J, Shackell MM, Richardson A, Poole-Wilson PA, Sutton GC. Prevalence of heart failure in three general practices in north west London. Br J Gen Practice. 1992;42:287–289[Web of Science][Medline]
  2. McMurray J, Hart W, Rhodes G. An evaluation of the economic cost of heart failure to the National Health Service in the United Kingdom. Br J Med Econ. 1993;6:99–110
  3. Ghali JK, Kay R, Shelton B. Contemporary aetiologies of left ventricular dysfunction and/or heart failure and their influence on prognosis. Circulation. 1992;86 (Suppl):2380
  4. Cowie MR, Mosterd A, Wood DA. The epidemiology of heart failure. Eur Heart J. 1997;18:208–225[Free Full Text]
  5. Opie LH. The multifarious spectrum of ischaemic left ventricular dysfunction: Relevance of new ischaemic syndromes. J Mol Cell Cardiol. 1996;28:2403–2414[CrossRef][Web of Science][Medline]
  6. Cowie, MR, Wood, DA, Coats, A, Incidence and aetiology of heart failure: a population-based study, Eur Heart J
  7. McKee PA, Castell WP, Mcnamara PM, Kannel WP. The natural history of congestive heart failure: The Framingham study. N Engl J Med. 1971;285:1441–1445[Web of Science][Medline]
  8. Remes J, Reunanen A, Aromaa A, Pyorala K. Incidence of heart failure in eastern Finland: a population-based surveillance study. Eur Heart J. 1992;13:588–593[Abstract/Free Full Text]
  9. Brookes CIO, Hart P, Keogh BE, Cleland JGF. Angiography and the aetiology of heart failure. Postgrad Med J. 1995;71:480–504[Abstract/Free Full Text]
  10. Bortman G, Sellanes M, Odell DS, Ring WS, Olivari M. Discrepency between Pre- and Post-diagnosis of end-stage dilated cardiomyopathy. Am J Cardiol. 1994;74:921–924[CrossRef][Web of Science][Medline]
  11. Fox KF, Cowie MR, Wood DA. Prevalence of coronary artery disease in new cases of heart failure: a population study. (Abstr) Eur Heart J. 1998;19 (Abstr Suppl):S223
  12. Braunwald E. Myocardial Infarction. Diseases of the Heart, 6th edn. Philadelphia: WB Saunders; 1996. p. 1184–1288
  13. The ISIS-2 collaborative group. Randomised trial of intra-venous streptokinase, oral aspirin, both or neither among 17187 cases of suspeted myocardial infarction: ISIS-2. Lancet. 1988;ii:349–360
  14. Stevenson R, Ranjadayalan K, Wilkinson P, Roberts R, Timis AD. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. Br Med J. 1993;307:349–353[Abstract/Free Full Text]
  15. Opie LH. Myocardial ischaemia—metabolic pathways and implications of increased glycolysis. Cardiovasc Drugs Ther. 1990;4:777–790
  16. Clarke K, O’Connor AJ, Willis RJ. Temporal relation between energy metabolism and myocardial function during ischaemia and reperfusion. Am J Physiol. 1987;253:H412–H421
  17. Deanfield JE, Maseri A, Selwyn AP. Myocardial ischaemia during daily life inpatients with stable angina: its relation to symptoms and heart rate changes. Lancet. 1983;2:753–758[Web of Science][Medline]
  18. Gunning MG, Mulcahy D, Patel D. Recurrent transient ischaemic episodes during daily life do not cause deterioration in left ventricular function. A long-term follow-up study (Abstr). Eur Heart J. 1995;16 (Abstr Suppl):S421
  19. Heyndrickx GR, Millard RW, McRitchie RJ, Maroko PR, Vatner SF. Regional myocardial function and electrophysiological alterations after brief coronary occlusion in conscious dogs. J Clin Invest. 1975;56:978–985[Web of Science][Medline]
  20. Serruys PW, Wijns W, van den Brandt M. Left ventricular performance, regional blood flow, wall motion, and lactate metabolism during transluminal angioplasty. Circulation. 1994;70:25–36
  21. Nixon JV, Brown CN, Smitherman TC. Identification of transient and persistent segmental wall motion abnormalities in patients with unstable angina by two-dimensional echo-cardiography. Circulation. 1982;658:1497–1503
  22. Du Toit J, Opie LH. Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ Res. 1992;70:960–967[Abstract/Free Full Text]
  23. Ehring TE, Heusch G. Stunned myocardium and the attenuation of stunning by calcium antagonists. Am J Cardiol. 1995;75:61E–67E[CrossRef][Medline]
  24. Shen Y-T, Vatner SF. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning. Circ Res. 1995;76:479–488[Abstract/Free Full Text]
  25. Rahimtoola SH. A perspective on three large multicenter randomised clinical trials of coronary bypass surgery for chronic stable angina. Circulation. 1985;72 (Supp V):123–125
  26. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211–221[CrossRef][Web of Science][Medline]
  27. Ross Jr J. Myocardial perfusion-contraction matching: implications for coronary heart disease and hibernation. Circulation. 1991;83:1076–1082[Abstract/Free Full Text]
  28. Hearse DJ. Myocardial hibernation. A form of endogenous protection? Eur Heart J. 1997;18 (Suppl A):A2–A7
  29. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischaemia: a delay of lethal cell injury in ischaemic myocardium. Circulation. 1986;74:1124–1136[Abstract/Free Full Text]
  30. Speechly-Dick ME, Glover GJ, Yellon DM. Does ischaemic preconditioning in the human heart involve protein kinase C and the ATP-dependent K+ channel? Studies in an atrial in vivo model. Circ Res. 1995;77:1030–1035[Abstract/Free Full Text]
  31. Kloner RA, Yellon DM. Does ischaemic preconditioning occur in patients. J Am Coll Cardiol. 1994;24:1133–1142[Abstract]
  32. Tillisch JG, Brunken R, Marshall R. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med. 1986;315:884–888
  33. Dilsizian V, Arrighi JA, Diodatti JG. Myocardial viability inpatients with chronic coronary artery disease Comparison of 99mTc-Sestamibi with thallium reinjection and [18F]Fluorodeoxyglucose. Circulation. 1994;89:578–587[Abstract/Free Full Text]
  34. Cigarroa CG, de Fillippi CR, Brickner ME. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularisation. Circulation. 1993;88:430–436[Abstract/Free Full Text]
  35. Baer FM, Voth E, Schneider CA. Comparison of low-dose dobutamine-gradient echo magnetic resonance imaging and positron emission tomography with [18F] fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation. 1995;91:1006–1015[Abstract/Free Full Text]
  36. Beller GA. Assessment of myocardial viability. Curr Opinion Cardiol. 1997;12:459–467[Web of Science][Medline]
  37. Perrone-Filarde P, Pace L, Prastaro M. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularisation in patients with coronary artery disease. Circulation. 1995;91:2256–2265
  38. LaCanna G, Alfieri O, Giubbini R. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23:617–626[Abstract]
  39. Di Carli MF, Asgarzadie BA, Schelbert HR. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularisation in patients with ischaemic cardiomyopathy. Circulation. 1995;92:3436–3444[Abstract/Free Full Text]
  40. Bonow RO. The hibernating myocardium: Implications for the management of congestive heart failure. Am J Cardiol. 1995;75:17A–25A[CrossRef][Medline]
  41. Cowie MR, Suresh V, Wood DA. The prognosis of heart failure: a population-based series. (Abstr) Eur Heart J. 1997;18:S596
  42. Clark ML, Price AB, Williams CB. Tumours of the gastro-intestinal tract. Weatherall DJ, Ledingham JGG, Warrell DA. Oxford Textbook of Medicine, 3rd edn. Oxford: Oxford University Press; 1996. p. 1980–1994
  43. Ho KK, Pisky JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol. 1993;22:6A–13A[Medline]
  44. Franciosa JA, Wilen M, Ziesche S, Cohn JN. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1983;51:831–836[CrossRef][Web of Science][Medline]
  45. Adams KF, Dunlap SH, Sueta CA. Relation between gender, etiology and survival in patient with symptomatic heart failure. J Am Coll Cardiol. 1996;28:1781–1788[Abstract]
  46. Di Carli MF, Davidson M, Little R. Value of metabolic imaging with positron emission tomography in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol. 1994;73:527–533[CrossRef][Web of Science][Medline]
  47. Scandinavian Simvastatin Survival Study Group. A randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–1389[CrossRef][Web of Science][Medline]
  48. Kjekshus J, Pederson T. Lowering of cholesterol with simvastatin may prevent development of heart failure in patients with coronary heart disease (Abstr). J Am Coll Cardiol. 1995;25:282A
  49. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685–691[Abstract]
  50. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293–302[Abstract]
  51. Acute Infarction Ramipril Efficacy (AIRE) Investigators. Effects of ramipril on morbidity and mortality of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821–828[Web of Science][Medline]
  52. Packer M, Bristow MR, Cohn JN. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349–1355[Abstract/Free Full Text]
  53. Waagstein F, Bristow MR, Swedberg K. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet. 1993;342:1441–1446[CrossRef][Web of Science][Medline]
  54. CIBIS Investigators and Committees. A randomised trial of Beta-blockade in heart failure: The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation. 1994;90:1765–1773[Medline]
  55. Packer M, O’Conner CM, Ghali JK. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med. 1996;335:1107–1114[Abstract/Free Full Text]
  56. Pouleur H, Rousseau MF. Nisoldipine in ischaemic left ventricular dysfunction. Eur Heart J. 1993;14 (Suppl A):45–47
  57. Carmelo A, Milano MD, William D. Coronary artery bypass in patients with severely depressed ventricular function. Ann Thorac Surg. 1993;56:487–493[Abstract]
  58. Rahimtoola SH. Coronary bypass surgery for chronic angina—1981: a perspective. Circulation. 1982;65:225–241[Free Full Text]
  59. Alderman EL, Bourassa MG, Cohen LS, CASS investigators. Ten year follow up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 1990;82:1629–1646[Abstract/Free Full Text]
  60. Bounous EP, Mark DB, Pollock BG. Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation. 1988;78 (Suppl):1–157
  61. RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet. 1997;350:461–468[CrossRef][Web of Science][Medline]
  62. Gioia G, Powers J, Heo J. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischaemic cardiomyopathy. Am J Cardiol. 1995;75:759–762[CrossRef][Web of Science][Medline]
  63. Dreyfus G, Duboc D, Blasco A. Coronary surgery can be an alternative to heart transplantation in selected patients with end-stage ischaemic heart disease (Abstr). Eur J Cadiothorac Surg. 1993;7:482–487[Abstract]
  64. Di Carli MF, Asgarzadie F, Schelbert HR. Quantitative relationship between myocardial viability and improvement in heart failure symptoms after revascularisation in patients with ischaemic cardiomyopathy. Ciculation. 1995;92:3436–3444
  65. Townsend JN, Pagano D, Allen SM. Results of surgical revascularisation in ischaemic heart failure without angina. Eur J Cardiothorac Surg. 1995;9:507–510[Abstract]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
A. Repetto, B. D. Bello, M. Pasotti, M. Agozzino, M. Vigano, C. Klersy, L. Tavazzi, and E. Arbustini
Coronary atherosclerosis in end-stage idiopathic dilated cardiomyopathy: an innocent bystander?
Eur. Heart J., August 1, 2005; 26(15): 1519 - 1527.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. QUASCHNING, L. V. D'USCIO, S. SHAW, H.-J. GRONE, F. RUSCHITZKA, and T. F. LUSCHER
Vasopeptidase Inhibition Restores Renovascular Endothelial Dysfunction in Salt-Induced Hypertension
J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2280 - 2287.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
T. Quaschning, L. V. d'Uscio, S. Shaw, H. Viswambharan, F. T. Ruschitzka, and T. F. Luscher
Chronic vasopeptidase inhibition restores endothelin-converting enzyme activity and normalizes endothelin levels in salt-induced hypertension
Nephrol. Dial. Transplant., June 1, 2001; 16(6): 1176 - 1182.
[Abstract] [Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fox, K.F.
Right arrow Articles by Sutton, G.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fox, K.F.
Right arrow Articles by Sutton, G.C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?